Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -28.67%282.13K | -43.20%272.28K | -53.49%1.3M | -40.24%235.97K | -64.19%188.43K | -40.32%395.53K | -60.37%479.38K | -19.54%2.79M | -63.33%394.9K | -34.93%526.13K |
| Operating revenue | -28.67%282.13K | -43.20%272.28K | -53.49%1.3M | -40.24%235.97K | -64.19%188.43K | -40.32%395.53K | -60.37%479.38K | -19.54%2.79M | -63.33%394.9K | -34.93%526.13K |
| Cost of revenue | -42.53%146.96K | -42.86%200.96K | -33.54%1.24M | -47.40%434.82K | -46.33%195.73K | -39.41%255.72K | 41.11%351.7K | 15.43%1.86M | -3.75%826.66K | 122.23%364.7K |
| Gross profit | -3.32%135.17K | -44.14%71.32K | -83.89%225.49K | -193.00%-34.71K | -104.52%-7.29K | -41.93%139.81K | -86.71%127.68K | -24.67%1.4M | -82.89%37.32K | -74.95%161.44K |
| Operating expense | -39.32%467.72K | -54.73%334.41K | 10.96%3.02M | 876.26%726.38K | -22.01%782.34K | 7.70%770.81K | 11.66%738.62K | -14.20%2.72M | -92.97%74.4K | 60.00%1M |
| Selling and administrative expenses | -42.55%176.39K | -79.39%67.71K | 0.70%1.14M | 868.49%343.65K | -76.61%160.58K | -7.59%307.05K | 108.28%328.51K | -39.27%1.13M | -103.71%-44.72K | 459.07%686.59K |
| -Selling and marketing expense | --0 | --0 | 44.53%179.96K | 246.06%154.96K | -67.64%10K | -23.89%15K | --0 | -56.06%124.51K | -42.54%44.78K | -14.46%30.9K |
| -General and administrative expense | -39.60%176.39K | -79.39%67.71K | -4.72%959.83K | 310.83%188.69K | -77.03%150.58K | -6.56%292.05K | 155.46%328.51K | -36.26%1.01M | -107.94%-89.5K | 656.40%655.69K |
| Depreciation amortization depletion | -56.34%137.07K | -52.51%135.28K | 29.31%1.31M | -32.86%344.08K | 66.52%369.63K | 117.79%313.97K | 108.85%284.84K | 92.67%1.01M | 148.65%512.46K | 15.94%221.98K |
| -Depreciation and amortization | -56.34%137.07K | -52.51%135.28K | 29.31%1.31M | -32.86%344.08K | 66.52%369.63K | 117.79%313.97K | 108.85%284.84K | 92.67%1.01M | 148.65%512.46K | 15.94%221.98K |
| Other taxes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --172.51K | ---- | ---- |
| Other operating expenses | 2.98%154.26K | 4.91%131.42K | -1.29%565.85K | 109.83%38.65K | 166.56%252.13K | -37.39%149.79K | -65.90%125.27K | -26.49%573.24K | -11.80%-393.34K | -69.75%94.59K |
| Operating profit | 47.30%-332.55K | 56.94%-263.09K | -111.56%-2.79M | -1,952.32%-761.08K | 6.19%-789.63K | -32.86%-631K | -304.32%-610.93K | -0.63%-1.32M | 95.59%-37.08K | -4,909.52%-841.71K |
| Net non-operating interest income (expenses) | 40.04%-126.26K | 28.17%-128.45K | -56.56%-930.68K | 17.01%-325.43K | 41.98%-215.84K | -243.28%-210.58K | -65.10%-178.83K | -8.27%-594.45K | -10.81%-392.11K | -489.64%-372K |
| Non-operating interest expense | -40.04%126.26K | -28.17%128.45K | 56.56%930.68K | -17.01%325.43K | -41.98%215.84K | 243.28%210.58K | 65.10%178.83K | 8.27%594.45K | 10.81%392.11K | 483.87%372K |
| Other net income (expenses) | -3,192.20%-114.83K | -124.35%-100.01K | 59.87%-648.16K | 62.55%-594.57K | -131.13%-5.53K | -102.19%-3.49K | 62.35%-44.58K | -360.01%-1.62M | -791.93%-1.59M | 116.66%17.75K |
| Gain on sale of security | -33.26%-4.65K | 87.87%-5.41K | -155.02%-311.83K | 3.63%-258.24K | -102.20%-5.53K | -101.46%-3.49K | 34.28%-44.58K | 14.58%-122.28K | -90.36%-267.96K | 1,758.56%250.77K |
| Special income (charges) | ---110.18K | ---108.09K | 77.22%-349.82K | 75.41%-349.82K | --0 | --0 | --0 | -605.32%-1.54M | -553.26%-1.42M | ---113.33K |
| -Less:Other special charges | ---- | ---- | -105.35%-38.25K | ---- | ---- | ---- | ---- | 538.22%714.71K | ---- | ---- |
| -Less:Write off | --110.18K | --108.09K | -52.73%388.07K | -45.16%388.07K | --0 | --0 | --0 | 115.57%820.94K | 85.81%707.61K | --113.33K |
| Other non-operating income (expenses) | ---- | --13.49K | -68.38%13.49K | ---- | ---- | ---- | ---- | 338.68%42.64K | -43.21%102.49K | -30.90%-119.69K |
| Income before tax | 32.12%-573.64K | 41.09%-491.55K | -23.85%-4.37M | 16.65%-1.68M | 15.47%-1.01M | -124.34%-845.07K | -1,254.13%-834.34K | -59.58%-3.53M | -46.92%-2.02M | -18,728.71%-1.2M |
| Income tax | 0 | 0 | -394.02%-602.74K | -432.04%-602.74K | 0 | 0 | 0 | -42.32%205K | 181.53K | 23.47K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 32.12%-573.64K | 41.09%-491.55K | -0.91%-3.77M | 50.95%-1.08M | 17.09%-1.01M | -124.34%-845.07K | -1,254.13%-834.34K | -45.47%-3.73M | -27.21%-2.2M | -19,094.27%-1.22M |
| Net income continuous operations | 32.12%-573.64K | 41.09%-491.55K | -0.91%-3.77M | 50.95%-1.08M | 17.09%-1.01M | -124.34%-845.07K | -1,254.13%-834.34K | -45.47%-3.73M | -27.21%-2.2M | -19,094.27%-1.22M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 64.50%-299.97K | 41.09%-491.55K | 6.45%-3.93M | 53.42%-1.24M | 17.93%-1.01M | -124.34%-845.07K | -1,254.13%-834.34K | -63.74%-4.2M | -54.35%-2.67M | -19,288.04%-1.23M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 64.50%-299.97K | 41.09%-491.55K | 6.45%-3.93M | 53.42%-1.24M | 17.93%-1.01M | -124.34%-845.07K | -1,254.13%-834.34K | -63.74%-4.2M | -54.35%-2.67M | -19,288.04%-1.23M |
| Diluted earnings per share | 0 | 0.00%-0.01 | 0.00%-0.03 | 33.33%-0.02 | -0.01 | -292.16%-0.01 | -2,140.82%-0.01 | -50.00%-0.03 | -200.00%-0.03 | 0 |
| Basic earnings per share | 0 | 0.00%-0.01 | 0.00%-0.03 | 33.33%-0.02 | -0.01 | -292.16%-0.01 | -2,140.82%-0.01 | -50.00%-0.03 | -200.00%-0.03 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.